Source link : https://www.newshealth.biz/health-news/us-fda-puts-clinical-hold-on-ataras-trials-for-cancer-cell-therapies/
(Reuters) -Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell therapies, sending the drug developer’s shares down more than 4% in premarket trading. The clinical hold applies to the studies of Atara’s experimental treatment tabelecleucel for a rare cancer, and ATA3219, which is being […]
Author : News Health
Publish date : 2025-01-21 12:42:26
Copyright for syndicated content belongs to the linked Source.